Brain tumours in Sweden 1996: care and costs

Blomqvist, Peter; Lycke, Jan; Strang, Peter; Törnqvist, Helene; Ekbom, Anders

doi:10.1136/jnnp.69.6.792

Cited by 40 publications

(42 citation statements)

References 36 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…For the year 1996, the AYPLL measure in Australia due to all brain and CNS tumors was 16.3 years, whereas in the UK, the data from 1990 to 1994 suggest an AYPLL measure of 20.1 years [5,16] . In a study in Sweden, the average loss of productive life years (up to 64 years) due to brain tumors in 1996 was 6.6 years [17] .…”

Section: Discussionmentioning

confidence: 99%

Average Years of Potential Life Lost in Those Who Have Died from Brain and CNS Tumors in the USA

Thuppal

Propp²,

McCarthy³

2006

Neuroepidemiology

View full text Add to dashboard Cite

The aim of this study was to quantify the impact of all primary malignant and nonmalignant brain and central nervous system (CNS) tumors on mortality in the USA in terms of years of life lost, an indicator of premature mortality in the population. In this study, US mortality data for the year 2001 from the National Center for Health Statistics and life tables from the US Census Bureau were used. Person-years of potential life lost (PYPLL) and average years of potential life lost (AYPLL) were calculated for all deaths due to brain and CNS tumors as an underlying cause. 16,819 deaths due to brain and CNS tumors occurred in 2001, leading to a total loss of 357,483 person-years of life and an average loss of 21.3 years (AYPLL). Hispanic men and women had an AYPLL of 31.7 and 33.9 years, respectively, a figure substantially higher than other race and ethnicity categories. Malignant tumors led to an AYPLL of 25 years, which was significantly higher than the AYPLL of 19 years due to nonmalignant tumors. The relative impact of tumors arising in the various anatomical sites in the brain and CNS among adults and among children was not similar. The use of population survival indicators, such as PYPLL and AYPLL, will help better understanding of the effect of racial, ethnic, gender and age differences on the mortality due to malignant and nonmalignant brain and CNS tumors. Information on years of life lost, as well as mortality data, will be useful in focusing research priorities and resources in this field.

show abstract

Section: Discussionmentioning

confidence: 99%

Average Years of Potential Life Lost in Those Who Have Died from Brain and CNS Tumors in the USA

Thuppal

Propp²,

McCarthy³

2006

Neuroepidemiology

View full text Add to dashboard Cite

show abstract

“…Brain tumors represent 1-2% of all newly diagnosed tumors and account for 2% of all cancer-related deaths. As with other neurologic diseases, brain tumors are particularly expensive to treat, with HAIs adding to costs 3,12 . In this study we evaluate the epidemiology, additional length of stay, incremental costs and patient outcomes due to hospital-acquired infections in brain tumor patients.…”

Section: Introductionmentioning

confidence: 99%

Clinical and economic analysis of hospital acquired infections in patients diagnosed with brain tumor in a tertiary hospital

Undabeitia¹,

Liu²,

Catalán³

et al. 2011

Neurocirugía

View full text Add to dashboard Cite

SummaryObjectives. To analyze the relationship between hospital acquired infections and clinical outcomes, duration of stay, and cost per infectious episode in patients diagnosed with brain tumors in our service.Materials and methods. We conducted a retrospective study on patients diagnosed with brain tumors and admitted to the department of neurosurgery in the Cruces Hospital of the University of the Basque Country between January 1st, 2007 and December 31st, 2007. We collected demographics, responsible pathogens, infection location, length of hospitalization, and costs of various medical and surgical procedures performed.Results. We reviewed 139 patients that accumulated 210 hospital visits. We found 34 episodes of hospital acquired infections (16.25% of patients). The most frequent infections were that of the lower respiratory tract, urinary tract, and surgical site. We found that patients with HAIs had a significantly lower final KPS score (sig <0.01), greater mean cost of stay (17097€, sig.<0.01), and longer length of stay (15.45 days, sig<0.01). We did not find a significant difference in mortality.Conclusions. We found significant association between the presence of HAIs and worse clinical outcomes, higher costs, and longer length of stay. The pathogens responsible and infection locations were similar to existing series in the literature. Although variability in study designs in the literature makes interpretation and comparison of results difficult, measures to prevent these complications can improve quality of care and reduce costs.KEY WORDS. Brain neoplasms. Infection. Costs. Análisis clínico económico de las infecciones nosocomiales en los pacientes diagnosticados de tumoración cerebral en un hospital terciario ResumenObjetivos. Analizar la relación entre la presencia de infección nosocomial y el resultado clínico final, la duración de la estancia y el coste del episodio en los pacientes diagnosticados de tumoración cerebral en nuestro servicio. Material y método. Realizamos un estudio retrospectivo incluyendo los pacientes ingresados en el Servicio de Neurocirugía del Hospital Universitario de Cruces con diagnostico de tumoración cerebral en el periodo comprendido entre el 1-1-2007 y el 31-12 del 2007. Recogimos variables demográficas, los microorganismos responsables y la localización de las distintas infecciones, el tiempo de ingreso y los costes de los distintos procedimientos médicos y quirúrgicos realizados.Resultados. Recogimos 139 pacientes, que acumularon un total de 210 episodios. Encontramos la presencia de infecciones nosocomiales en 34 episodios (16,25%). La localización mas frecuente fue la respiratoria, seguida del tracto urinario y la infección de herida quirúr-gica. Encontramos unas diferencias significativas en la situación funcional al alta (sig <0.01), el coste medio de los episodios (17097€, sig.<0.01) y en la estancia media (15.45 días, sig.<0.01). No encontramos diferencias significativas con respecto a la mortalidad.Conclusiones. Encontramos asociaciones significativas entre la...

show abstract

“…Costs of treatment for a brain tumour were extracted from Blomqvist 125 and are reported in Table 30. The authors reported direct and indirect costs of brain tumour.…”

mentioning

confidence: 99%

Structural neuroimaging in psychosis: a systematic review and economic evaluation

Albon¹,

Tsourapas²,

Frew³

et al. 2008

Health Technol Assess

View full text Add to dashboard Cite

Non-UK purchasers will have to pay a small fee for post and packing. For European countries the cost is £2 per monograph and for the rest of the world £3 per monograph.You can order HTA monographs from our Despatch Agents:-fax (with credit card or official purchase order) -post (with credit card or official purchase order or cheque) -phone during office hours (credit card only).Additionally the HTA website allows you either to pay securely by credit card or to print out your order and then post or fax it. NHS libraries can subscribe free of charge. Public libraries can subscribe at a very reduced cost of £100 for each volume (normally comprising 30-40 titles). The commercial subscription rate is £300 per volume. Please see our website for details. Subscriptions can only be purchased for the current or forthcoming volume. Contact details are as follows: Payment methods Paying by chequeIf you pay by cheque, the cheque must be in pounds sterling, made payable to Direct Mail Works Ltd and drawn on a bank with a UK address. Paying by credit cardThe following cards are accepted by phone, fax, post or via the website ordering pages: Delta, Eurocard, Mastercard, Solo, Switch and Visa. We advise against sending credit card details in a plain email. Paying by official purchase orderYou can post or fax these, but they must be from public bodies (i.e. NHS or universities) within the UK. We cannot at present accept purchase orders from commercial companies or from outside the UK. How do I get a copy of HTA on CD?Please use the form on the HTA website (www.hta.ac.uk/htacd.htm). Or contact Direct Mail Works (see contact details above) by email, post, fax or phone. HTA on CD is currently free of charge worldwide.The website also provides information about the HTA Programme and lists the membership of the various committees. HTA NIHR Health Technology Assessment ProgrammeT he Health Technology Assessment (HTA) Programme, part of the National Institute for Health Research (NIHR), was set up in 1993. It produces high-quality research information on the effectiveness, costs and broader impact of health technologies for those who use, manage and provide care in the NHS. 'Health technologies' are broadly defined as all interventions used to promote health, prevent and treat disease, and improve rehabilitation and long-term care. The research findings from the HTA Programme directly influence decision-making bodies such as the National Institute for Health and Clinical Excellence (NICE) and the National Screening Committee (NSC). HTA findings also help to improve the quality of clinical practice in the NHS indirectly in that they form a key component of the 'National Knowledge Service'. The HTA Programme is needs-led in that it fills gaps in the evidence needed by the NHS. There are three routes to the start of projects. First is the commissioned route. Suggestions for research are actively sought from people working in the NHS, the public and consumer groups and professional bodies such as royal colleges and NHS trusts. These sugges...

show abstract

Brain tumours in Sweden 1996: care and costs

Cited by 40 publications

References 36 publications

Average Years of Potential Life Lost in Those Who Have Died from Brain and CNS Tumors in the USA

Average Years of Potential Life Lost in Those Who Have Died from Brain and CNS Tumors in the USA

Clinical and economic analysis of hospital acquired infections in patients diagnosed with brain tumor in a tertiary hospital

Structural neuroimaging in psychosis: a systematic review and economic evaluation

Contact Info

Product

Resources

About